NextGen General Pvt. Ltd.

,

Vingraf 0.25mg Tacrolimus Capsule

130.00

Usage/Application Cardiovascular
Packaging Type 6×10 Capsules
Treatment Used As An Immunosuppressant To Prevent Organ Transplant Rejection, Working By Reducing The Activity
Strength 0.25 mg
Brand Vingraf
Composition Tacrolimus

Vingraf 0.5mg is a Tacrolimus-based immunosuppressant manufactured by Emcure Pharmaceuticals Ltd. It is commonly prescribed as part of a treatment regimen under medical supervision. The formulation is designed for oral administration and is produced under strict quality standards to ensure effectiveness and safety. Vingraf 0.5mg is available in strip/blister packaging, maintaining its stability and quality.

Key Features of Vingraf 0.5mg:

  • Active Ingredient: Tacrolimus 0.5mg.
  • Manufactured By: Emcure Pharmaceuticals Ltd.
  • Packaging Size: Available in 10 capsules per strip.
  • Usage: Used under medical guidance as part of prescribed treatment regimens.
  • Secure Packaging: Ensures product stability and effectiveness.

Additional Information:

Vingraf 0.5mg should be taken as prescribed by a healthcare professional. It is important to follow all medical guidelines before starting the medication. The capsules should be stored in a cool, dry place away from direct sunlight to maintain their quality and effectiveness.

Reviews

There are no reviews yet.

Be the first to review “Vingraf 0.25mg Tacrolimus Capsule”

Your email address will not be published. Required fields are marked *

Scroll to Top